Last reviewed · How we verify

NCT05130528

Therapeutic Intervention Supporting Development From NICU to 6 Months for Infants Post Hypoxic-Ischemic Encephalopathy

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Sensorimotor Intervention in Cerebral Palsy in 12 participants. Completed in 30 April 2024.

Timeline
18 February 2022
Primary endpoint
30 April 2024
30 April 2024

Quick facts

Lead sponsorUniversity of Southern California
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment12
Start date18 February 2022
Primary completion30 April 2024
Estimated completion30 April 2024
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

Under 6 Months, any sex, with Cerebral Palsy or Hypoxic-Ischemic Encephalopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the feasibility and begin to evaluate the effect of a sensorimotor intervention (SMI) provided in the first 6 months of life for infants with hypoxic-ischemic encephalopathy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy.
    Ranjan AK, Gulati A. · · 2023 · cited 41× · PMID 37892791 · DOI 10.3390/jcm12206653

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05130528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing